These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 33628009)

  • 1. Delayed Intravitreal Anti-VEGF Therapy for Patients During the COVID-19 Lockdown: An Ethical Endeavor.
    Elfalah M; AlRyalat SA; Toro MD; Rejdak R; Zweifel S; Nazzal R; Abu-Ameerh M; Ababneh O; Gharaibeh A; Sharif Z; Meqbil J; AlShawabkeh M; Alwreikat A; Al Bdour M; Al-Hussaini M; Yousef YA
    Clin Ophthalmol; 2021; 15():661-669. PubMed ID: 33628009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Impact of the SARS-CoV-2 pandemic on diabetic macular edema and prognostic factors].
    Khodriss C; El Harch I; Bennis A; Chraibi F; El Fakir S; Abdellaoui M; Tachfouti N; Benatiya Andaloussi I
    J Fr Ophtalmol; 2021 Nov; 44(9):1313-1318. PubMed ID: 34538511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of monitoring wet age-related macular degeneration patients during Coronavirus disease 19 pandemic: A retrospective study of assessment of functional and structural outcomes.
    Tsiropoulos GN; Vallee R; Gallo Castro D; Ambresin A
    J Fr Ophtalmol; 2022 Oct; 45(8):852-859. PubMed ID: 35908993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of COVID-19-related lockdown on retinal disorders treated with intravitreal injections.
    Brar M; Grewal SPS; Grewal DS; Sharma M; Dogra MR
    Oman J Ophthalmol; 2022; 15(2):168-174. PubMed ID: 35937740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion.
    Ip MS; Gottlieb JL; Kahana A; Scott IU; Altaweel MM; Blodi BA; Gangnon RE; Puliafito CA
    Arch Ophthalmol; 2004 Aug; 122(8):1131-6. PubMed ID: 15302652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macular dynamics and visual acuity prognosis in retinal vein occlusions - ways to connect.
    Dărăbuș DM; Pac CP; Roşca C; Munteanu M
    Rom J Ophthalmol; 2023; 67(3):312-324. PubMed ID: 37876516
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravitreal triamcinolone treatment for macular edema associated with central retinal vein occlusion and hemiretinal vein occlusion.
    Cekiç O; Chang S; Tseng JJ; Barile GR; Weissman H; Del Priore LV; Schiff WM; Weiss M; Klancnik JM
    Retina; 2005; 25(7):846-50. PubMed ID: 16205562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Experience in the Administration of Intravitreal Injection Therapy at a Tertiary University Hospital in Jordan During the COVID-19 Lockdown.
    Saleh OA; Jammal H; Alqudah N; Alqudah A; Abu-Yaghi N
    Clin Ophthalmol; 2020; 14():2473-2480. PubMed ID: 32943831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of delayed anti-vascular endothelial growth factor treatment for retinal diseases during the COVID-19 lockdown.
    Bulut MN; Sönmez HS; Gökçe G; Ağaçkesen A; Bulut K; Hacısalihoğlu A; Arsan A; Şimşek Ş
    Photodiagnosis Photodyn Ther; 2021 Sep; 35():102449. PubMed ID: 34314862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline Characteristics and Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema in Participants With Hemiretinal Vein Occlusion Compared With Participants With Central Retinal Vein Occlusion: Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Report 18.
    Scott IU; Oden NL; VanVeldhuisen PC; Ip MS; Blodi BA;
    JAMA Ophthalmol; 2022 May; 140(5):458-464. PubMed ID: 35323843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study.
    Iturralde D; Spaide RF; Meyerle CB; Klancnik JM; Yannuzzi LA; Fisher YL; Sorenson J; Slakter JS; Freund KB; Cooney M; Fine HF
    Retina; 2006 Mar; 26(3):279-84. PubMed ID: 16508427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term impact of delayed follow-up due to COVID-19 lockdown on patients with neovascular age-related macular degeneration.
    Szegedi S; Ebner C; Miháltz K; Wachter T; Vécsei-Marlovits PV
    BMC Ophthalmol; 2022 May; 22(1):228. PubMed ID: 35596203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longer-Term Anti-VEGF Therapy Outcomes in Neovascular Age-Related Macular Degeneration, Diabetic Macular Edema, and Vein Occlusion-Related Macular Edema: Clinical Outcomes in 130 247 Eyes.
    Ciulla TA; Hussain RM; Taraborelli D; Pollack JS; Williams DF
    Ophthalmol Retina; 2022 Sep; 6(9):796-806. PubMed ID: 35381391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.
    Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A
    Retina; 2006; 26(9):999-1005. PubMed ID: 17151486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
    Goff MJ; Johnson RN; McDonald HR; Ai E; Jumper JM; Fu A
    Retina; 2007; 27(4):432-8. PubMed ID: 17420694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting the visual outcomes and central macular thickness in diabetic maculopathy after intravitreal bevacizumab.
    Rizwan A; Asghar A; Yasmeen N; Hasan Naqvi SA
    J Pak Med Assoc; 2022 Nov; 72(11):2213-2217. PubMed ID: 37013289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [What can anti-VEGF therapy achieve in clinical routine? : Effectiveness of anti-VEGF therapy in patients with macular diseases in clinical routine on 1492 eyes in Austria].
    Wiesinger K; Reinelt P; Ennemoser A; Edelmayr M; Schönherr U
    Ophthalmologe; 2017 Jul; 114(7):639-645. PubMed ID: 27815675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion.
    Patel PJ; Zaheer I; Karia N
    Eye (Lond); 2008 Jan; 22(1):60-4. PubMed ID: 16902493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intravitreal aflibercept on recalcitrant diabetic macular edema.
    Klein KA; Cleary TS; Reichel E
    Int J Retina Vitreous; 2017; 3():16. PubMed ID: 28373914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short- and Long-Term Visual Outcomes in Patients Receiving Intravitreal Injections: The Impact of the Coronavirus 2019 Disease (COVID-19)-Related Lockdown.
    Douglas VP; Douglas KAA; Vavvas DG; Miller JW; Miller JB
    J Clin Med; 2022 Apr; 11(8):. PubMed ID: 35456189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.